Notice of Interim Results

July 27, 2017 at 9:25 AM

Chippenham, UK, 27 July 2017: Vectura Group plc (LSE: VEC) (“the Group”), an industry-leading inhaled airways disease focused business, plans to announce its Interim Results for the six-month period ending 30 June 2017 on Wednesday 6 September 2017.

James Ward-Lilley, Chief Executive Officer, and Andrew Derodra, Chief Financial Officer,will host a briefing for analysts at 9.30am on the morning of the results at the offices of Numis Securities Ltd., 10 Paternoster Square, London, EC4M 7LT. 

A live webcast of the meeting, with the presentation slides, will be available on Vectura’s website: http://www.vectura.com/investors/presentations-webcasts/.   

- ENDS -

For more information, please contact:

Vectura Group plc

+44   (0)1249 667700

Andrew Derodra – Chief Financial Officer

Fleur Wood –  Director Communications

Elizabeth Knowles – Director Investor Relations and Analysis

 

 

 

Consilium Strategic Communications

+44   (0)20 3709 5700

Mary-Jane Elliott / Sue Stuart / Jessica Hodgson

 vectura@consilium-comms.com

About Vectura

Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform. With our extensive range of device and formulation technologies, integrated capabilities and collaborations, we are a leader in the development of inhalation products, increasing our ability to help patients suffering from respiratory diseases. 

Vectura has eight inhaled, four non-inhaled and ten oral products marketed by partners with growing global royalty streams, and a portfolio of drugs in clinical development, a number of which have licence agreements with several global pharmaceutical and biotechnology companies including Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Ablynx, Grifols, Bayer, Chiesi, Almirall, Janssen, and Tianjin KingYork. For further information, please visit Vectura's website at www.vectura.com.

Tags:
back to top